Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

E. Negredo; L. Cruz; R. Paredes; L. Ruiz; C.R. Fumaz; A. Bonjoch; S. Gel; M. Tuldrà; M. Balagué; S. Johnston; A. Arnó; A. Jou; C. Tural; G. Sirera; J. Romeu; B. Clotet

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

E. Negredo, L. Cruz, R. Paredes, L. Ruiz, C.R. Fumaz, A. Bonjoch, S. Gel, M. Tuldrà, M. Balagué, S. Johnston, A. Arnó, A. Jou, C. Tural, G. Sirera, J. Romeu, B. Clotet

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca

167 Cites (Scopus)

Idioma original	Anglès
Pàgines (de-a)	504-510
Revista	Clinical Infectious Diseases
Volum	34
Número	4
Estat de la publicació	Publicada - 1 de gen. 2002

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

Altres arxius i enllaços

https://www.scopus.com/pages/publications/0037082965

Com citar-ho

Negredo, E., Cruz, L., Paredes, R., Ruiz, L., Fumaz, C. R., Bonjoch, A., Gel, S., Tuldrà, M., Balagué, M., Johnston, S., Arnó, A., Jou, A., Tural, C., Sirera, G., Romeu, J., & Clotet, B. (2002). Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. Clinical Infectious Diseases, 34(4), 504-510.

@article{97e4ddc907c64ab1b105e617f13e245e,

title = "Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression",

author = "E. Negredo and L. Cruz and R. Paredes and L. Ruiz and C.R. Fumaz and A. Bonjoch and S. Gel and M. Tuldr{\`a} and M. Balagu{\'e} and S. Johnston and A. Arn{\'o} and A. Jou and C. Tural and G. Sirera and J. Romeu and B. Clotet",

year = "2002",

month = jan,

day = "1",

language = "English",

volume = "34",

pages = "504--510",

number = "4",

}

Negredo, E, Cruz, L, Paredes, R, Ruiz, L, Fumaz, CR, Bonjoch, A, Gel, S, Tuldrà, M, Balagué, M, Johnston, S, Arnó, A, Jou, A, Tural, C, Sirera, G, Romeu, J & Clotet, B 2002, 'Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression', Clinical Infectious Diseases, vol. 34, núm. 4, pàg. 504-510.

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. / Negredo, E.; Cruz, L.; Paredes, R. et al.
In: Clinical Infectious Diseases, Vol. 34, Núm. 4, 01.01.2002, pàg. 504-510.

Producció científica: Contribució a revista › Article › Recerca

TY - JOUR

T1 - Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

AU - Negredo, E.

AU - Cruz, L.

AU - Paredes, R.

AU - Ruiz, L.

AU - Fumaz, C.R.

AU - Bonjoch, A.

AU - Gel, S.

AU - Tuldrà, M.

AU - Balagué, M.

AU - Johnston, S.

AU - Arnó, A.

AU - Jou, A.

AU - Tural, C.

AU - Sirera, G.

AU - Romeu, J.

AU - Clotet, B.

PY - 2002/1/1

Y1 - 2002/1/1

UR - https://www.scopus.com/pages/publications/0037082965

M3 - Article

SN - 1058-4838

VL - 34

SP - 504

EP - 510

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 4

ER -